Pharma

Your Article Summary

See Latest Articles

Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Teva Pharmaceutical Industries, 07/02/09

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application to market a generic version of Ortho McNeil Janssen's oral contraceptive, Ortho Tri-Cyclen Lo. Shipment of this product, for which Teva's trade name is Tri-Lo Sprintec, has commenced.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

US FDA approves new indication for CRESTOR
AstraZeneca, 02/09/10

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott, 02/09/10

FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10

 See all of Drug/Product Approvals

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott, 02/09/10

Synthon announces European approvals for Raloxifene
Synthon, 02/09/10

Study Suggests Slide-On Endosheath System Provides Several Advantages Over Traditional Germicidal Immersion
Medtronic, 02/08/10

 See all of Medical Devices/Products